Deccan Nutraceuticals is an API manufacturer based in India. It holds one active US drug master file and one valid CEP. Its most recent recorded inspection, by US FDA, closed on 20 April 2023 as NAI. Customs aggregates show $2.0M of exports covering 84 molecules to 19 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Pune, India | Not on file |
| Pune, India | 3007607026 |
| Molecule | Regulators | Docs |
|---|---|---|
| Digoxin | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $442K | 8 |
| 2025 | Not reported | $2.0M | 19 |
| 2024 | Not reported | $1.2M | 17 |
| 2023 | Not reported | $1.1M | 11 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Deccan Nutraceuticals comes back tiered against every other supplier able to file there.
Start for free